Due to the wide influences of DUSP22 on MAPKs activation, inflammation- and fibrosis-associated diseases or responses, we hypothesized that there may be a potential functional involvement of DUSP22 in NASH pathogenesis and associated HCC. This evidence concerns the gene DUSP22 and metabolic dysfunction-associated steatohepatitis.